Immunovant, Inc. (IMVT)

NASDAQ: IMVT · IEX Real-Time Price · USD
32.31
-0.21 (-0.65%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Immunovant Market Cap

Immunovant has a market cap or net worth of $4.65 billion as of March 28, 2024. Its market cap has increased by 125.32% in one year.

Market Cap
4.65B
Enterprise Value
3.96B
1-Year Change
125.32%
Ranking
Category
Stock Price
$32.31

Market Cap Chart

Since May 10, 2019, Immunovant's market cap has increased from $128.30M to $4.65B, an increase of 3,523.20%. That is a compound annual growth rate of 108.44%.

History

DateMarket Cap% Change
Mar 28, 20244.69B-0.65%
Mar 27, 20244.72B3.47%
Mar 26, 20244.57B0.67%
Mar 25, 20244.54B-3.04%
Mar 22, 20244.68B-2.69%
Mar 21, 20244.81B4.81%
Mar 20, 20244.59B1.54%
Mar 19, 20244.52B2.71%
Mar 18, 20244.40B-0.85%
Mar 15, 20244.44B-0.55%
Mar 14, 20244.46B-3.52%
Mar 13, 20244.62B1.02%
Mar 12, 20244.58B-1.38%
Mar 11, 20244.64B0.79%
Mar 8, 20244.60B-2.31%
Mar 7, 20244.71B-1.88%
Mar 6, 20244.80B-2.68%
Mar 5, 20244.94B-2.22%
Mar 4, 20245.05B-1.59%
Mar 1, 20245.13B-0.20%
Feb 29, 20245.14B-6.08%
Feb 28, 20245.47B-1.82%
Feb 27, 20245.57B0.55%
Feb 26, 20245.54B3.11%
Feb 23, 20245.38B2.81%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition